Monlunabant
A Study to Explore the PK and PD of INV-202 in Metabolic Syndrome
Inversago Pharma · Phase 1 · Completed · Enrollment 37
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| INV-202 | n/r | n/r | n/r | n/r | n/r |
| Placebo | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.